Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01296516 · ClinicalTrials.gov registry record · NA

Postpartum Weight Loss and Exercise (PRIDE)

A NA study of Gestational Diabetes and Glucose Intolerance, sponsored by Pennington Biomedical Research Center.

Completed
Registry status
NA
Development phase
7
Enrollment target
1
Study location

NCT01296516 is a NA study of Gestational Diabetes and Glucose Intolerance that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 7 participants, below the 322-participant average among 41 other Gestational Diabetes trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01296516, a NA study of Gestational Diabetes and Glucose Intolerance, has completed, sponsored by Pennington Biomedical Research Center.

COMPLETED
Registry status
NA
Development phase
7 participants
Enrollment target
1
Study location

Study Summary

The overall objective of this pilot project is to test in 50 women with a history of gestational diabetes mellitus (GDM), the effectiveness and feasibility of an 8 month intensive lifestyle intervention to reduce the rate of metabolic abnormalities within 1 year after delivery.

Interventions

  • BEHAVIORAL Non-intervention group
  • BEHAVIORAL Face to face
  • BEHAVIORAL Telehelath Group

Study Locations (1)

Louisiana

  • Pennington Biomedical Research Center - Baton Rouge

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2011-02
Est. Completion 2017-12
Phase NA

What the Registry Record Tells You About NCT01296516

The ClinicalTrials.gov registry entry for NCT01296516 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 322-participant average among 41 other Gestational Diabetes trials with a reported enrollment target (98% lower). The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Gestational Diabetes appearing as the primary indexed condition, and to 3 interventions - of which Non-intervention group is the first listed.

NCT01296516 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.

Frequently Asked Questions

What is clinical trial NCT01296516 about?

NCT01296516 is a clinical study titled "Postpartum Weight Loss and Exercise (PRIDE)". The overall objective of this pilot project is to test in 50 women with a history of gestational diabetes mellitus (GDM), the effectiveness and feasibility of an 8 month intensive lifestyle intervention to reduce the rate of metabolic abnormalities within 1 year after delivery.

What is the current status of trial NCT01296516?

This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2011-02. Estimated completion is 2017-12.

What conditions does trial NCT01296516 study?

This clinical trial studies the following conditions: Gestational Diabetes, Glucose Intolerance.

What interventions are being tested in trial NCT01296516?

The interventions under investigation include: Non-intervention group (BEHAVIORAL), Face to face (BEHAVIORAL), Telehelath Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT01296516?

This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01296516 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gestational Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.